Aseptic Meningitis after Recovery from SARS-CoV-2 in an Allogeneic Stem Cell Transplant Recipient

Fahmin Basher, Jose F. Camargo, Meilin Diaz-Paez, Lazaros J. Lekakis, Denise L. Pereira

Research output: Contribution to journalArticlepeer-review

Abstract

SARS-CoV-2 emerged as a worldwide pandemic in late 2019 and initially was described as a primary respiratory illness. The clinical manifestations of COVID-19 are now known to encompass nearly all organ systems, including the central nervous system. We present a case of an allogeneic hematopoietic stem cell transplant recipient who recovered from documented SARS-CoV-2 infection and later presented with symptoms of meningitis. While cerebrospinal fluid analysis did not reveal any bacterial or viral etiologies, evidence of an inflammatory state, including ophthalmologic findings of episcleritis, indicate what is likely the first reported case of aseptic meningitis associated with SARS-CoV-2 infection after initial clinical recovery.

Original languageEnglish (US)
JournalClinical Medicine Insights: Case Reports
Volume14
DOIs
StatePublished - 2021

Keywords

  • COVID-19
  • Meningitis
  • SARS-CoV-2
  • allogenic stem cell transplant
  • coronavirus

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Aseptic Meningitis after Recovery from SARS-CoV-2 in an Allogeneic Stem Cell Transplant Recipient'. Together they form a unique fingerprint.

Cite this